Cingulate Inc. Common Stock CING
i
Market datapartial · fetched 2026-11-12T00:43:50.878Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:03:05.642384231Z
FundamentalsAlpha Vantage · unavailable
Cingulate Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 4.02 | 562.7% | 43.0% | |||
| 25Δ | 4.48 | 665.3% | 42.7% | |||
| 30Δ | 4.94 | 767.9% | 42.4% | |||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | 4.92 | 244.8% | 22.4% | |||
| 50Δ | 4.63 | 295.8% | 21.3% | |||
| 55Δ | 4.33 | 346.9% | 20.1% | |||
| 60Δ | 4.03 | 398.0% | 19.0% | |||
| 65Δ | 3.73 | 449.0% | 17.9% | |||
| 70Δ | 3.44 | 500.1% | 16.7% | |||
| 75Δ | 3.14 | 551.1% | 15.6% | |||
| 80Δ | 2.84 | 602.2% | 14.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.02
- IV
- 562.7%
- B/E move
- 43.0%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.48
- IV
- 665.3%
- B/E move
- 42.7%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.94
- IV
- 767.9%
- B/E move
- 42.4%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 4.92
- IV
- 244.8%
- B/E move
- 22.4%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 4.63
- IV
- 295.8%
- B/E move
- 21.3%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 4.33
- IV
- 346.9%
- B/E move
- 20.1%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 4.03
- IV
- 398.0%
- B/E move
- 19.0%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 3.73
- IV
- 449.0%
- B/E move
- 17.9%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 3.44
- IV
- 500.1%
- B/E move
- 16.7%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 3.14
- IV
- 551.1%
- B/E move
- 15.6%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 2.84
- IV
- 602.2%
- B/E move
- 14.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 160.23% |
Biotechnology
CLDX
Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment of various diseases.…
More →CLYM
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. The company is headquartered in Wilmington, Delaware.
More →CMPX
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple human diseases. The…
More →CNTB
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe…
More →COGT
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge,…
More →CORT
Description unavailable
More →